WA
TLOG

Whitebox Advisors’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Whitebox Advisors’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-49,800
Closed -$218K – 433
2015
Q1 		$218K Buy
+49,800
New +$250K 0.01% 327

Other funds holding TLOG

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whitebox Advisors's TLOG Position: Q2 2015 in Review

Whitebox Advisors sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q2 2015, closing a stake of 49,800 shares — an estimated $218K sold.

Whitebox Advisors first reported a position in TLOG in Q1 2015 and held it in 1 quarter. The position peaked at $218K in Q1 2015. 33 funds tracked by Wall St. Rank hold TLOG as of Q2 2015.

  • Whitebox Advisors reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q2 2015 after selling out during the quarter.
  • Whitebox Advisors sold 49,800 TetraLogic Pharmaceuticals Corporation shares in Q2 2015, an estimated $218K.
  • Whitebox Advisors first reported a position in TetraLogic Pharmaceuticals Corporation in Q1 2015 and held it in 1 quarter.
  • Whitebox Advisors's TetraLogic Pharmaceuticals Corporation position peaked at $218K in Q1 2015.
  • 33 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q2 2015.

Based on Whitebox Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.